These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 17418293

  • 21. HbA1c, Coronary atheroma progression and cardiovascular outcomes.
    Dykun I, Bayturan O, Carlo J, Nissen SE, Kapadia SR, Tuzcu EM, Nicholls SJ, Puri R.
    Am J Prev Cardiol; 2022 Mar; 9():100317. PubMed ID: 35112095
    [Abstract] [Full Text] [Related]

  • 22. Impact of body mass index and Framingham risk score on coronary artery plaque.
    Takeshita H, Shimada Y, Kobayashi Y, Nishioka H, Ehara S, Kataoka T, Yoshiyama M.
    Osaka City Med J; 2008 Jun; 54(1):31-9. PubMed ID: 18819263
    [Abstract] [Full Text] [Related]

  • 23. Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction.
    Bayturan O, Puri R, Tuzcu EM, Shao M, Wolski K, Schoenhagen P, Kapadia S, Nissen SE, Sanders P, Nicholls SJ.
    Eur J Prev Cardiol; 2017 Mar; 24(4):373-381. PubMed ID: 27837151
    [Abstract] [Full Text] [Related]

  • 24. Atheroma progression in hyporesponders to statin therapy.
    Kataoka Y, St John J, Wolski K, Uno K, Puri R, Tuzcu EM, Nissen SE, Nicholls SJ.
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):990-5. PubMed ID: 25722430
    [Abstract] [Full Text] [Related]

  • 25. Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials.
    Sipahi I, Tuzcu EM, Wolski KE, Nicholls SJ, Schoenhagen P, Hu B, Balog C, Shishehbor M, Magyar WA, Crowe TD, Kapadia S, Nissen SE.
    Ann Intern Med; 2007 Jul 03; 147(1):10-8. PubMed ID: 17606956
    [Abstract] [Full Text] [Related]

  • 26. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.
    Lansky AJ, Ng VG, Maehara A, Weisz G, Lerman A, Mintz GS, De Bruyne B, Farhat N, Niess G, Jankovic I, Lazar D, Xu K, Fahy M, Serruys PW, Stone GW.
    JACC Cardiovasc Imaging; 2012 Mar 03; 5(3 Suppl):S62-72. PubMed ID: 22421232
    [Abstract] [Full Text] [Related]

  • 27. Relationship between LDL, HDL, blood pressure and atheroma progression in the coronaries.
    Nicholls SJ.
    Curr Opin Lipidol; 2009 Dec 03; 20(6):491-6. PubMed ID: 19593124
    [Abstract] [Full Text] [Related]

  • 28. Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries.
    von Birgelen C, Hartmann M, Mintz GS, van Houwelingen KG, Deppermann N, Schmermund A, Böse D, Eggebrecht H, Neumann T, Gössl M, Wieneke H, Erbel R.
    Circulation; 2004 Sep 21; 110(12):1579-85. PubMed ID: 15364814
    [Abstract] [Full Text] [Related]

  • 29. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
    Puri R, Nissen SE, Libby P, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ.
    Circulation; 2013 Nov 26; 128(22):2395-403. PubMed ID: 24043299
    [Abstract] [Full Text] [Related]

  • 30. Visit-to-visit cholesterol variability correlates with coronary atheroma progression and clinical outcomes.
    Clark D, Nicholls SJ, St John J, Elshazly MB, Kapadia SR, Tuzcu EM, Nissen SE, Puri R.
    Eur Heart J; 2018 Jul 14; 39(27):2551-2558. PubMed ID: 29688308
    [Abstract] [Full Text] [Related]

  • 31. The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis.
    Bayturan O, Tuzcu EM, Lavoie A, Hu T, Wolski K, Schoenhagen P, Kapadia S, Nissen SE, Nicholls SJ.
    Arch Intern Med; 2010 Mar 08; 170(5):478-84. PubMed ID: 20212186
    [Abstract] [Full Text] [Related]

  • 32. Analysis of missing mechanism in IVUS imaging clinical trials with missing covariates.
    Hu M, Zhou T.
    J Biopharm Stat; 2011 Mar 08; 21(2):282-93. PubMed ID: 21391002
    [Abstract] [Full Text] [Related]

  • 33. Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study.
    Nicholls SJ, Sipahi I, Schoenhagen P, Wisniewski L, Churchill T, Crowe T, Goormastic M, Wolski K, Tuzcu EM, Nissen SE, ACTIVATE Investigators.
    Am Heart J; 2006 Jul 08; 152(1):67-74. PubMed ID: 16824833
    [Abstract] [Full Text] [Related]

  • 34. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound.
    von Birgelen C, Hartmann M, Mintz GS, Baumgart D, Schmermund A, Erbel R.
    Circulation; 2003 Dec 02; 108(22):2757-62. PubMed ID: 14623804
    [Abstract] [Full Text] [Related]

  • 35. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.
    Mani P, Uno K, St John J, Tuzcu EM, Nissen SE, Nicholls SJ.
    Am J Cardiol; 2014 Sep 01; 114(5):681-5. PubMed ID: 25030535
    [Abstract] [Full Text] [Related]

  • 36. Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
    Tardif JC, Grégoire J, L'Allier PL, Ibrahim R, Lavoie MA, LeMay M, Cohen E, Levesque S, Keller PF, Heinonen T, Guertin MC.
    Am J Cardiol; 2006 Jul 01; 98(1):23-7. PubMed ID: 16784914
    [Abstract] [Full Text] [Related]

  • 37. High-intensity interval training induces beneficial effects on coronary atheromatous plaques: a randomized trial.
    Vesterbekkmo EK, Aksetøy IA, Follestad T, Nilsen HO, Hegbom K, Wisløff U, Wiseth R, Madssen E.
    Eur J Prev Cardiol; 2023 Mar 27; 30(5):384-392. PubMed ID: 36562212
    [Abstract] [Full Text] [Related]

  • 38. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S, Nagao K, Hirayama A.
    Am J Cardiovasc Drugs; 2011 Dec 01; 11(6):411-7. PubMed ID: 22149320
    [Abstract] [Full Text] [Related]

  • 39. Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano.
    Nicholls SJ, Tuzcu EM, Sipahi I, Schoenhagen P, Crowe T, Kapadia S, Nissen SE.
    J Am Coll Cardiol; 2006 Mar 07; 47(5):992-7. PubMed ID: 16516083
    [Abstract] [Full Text] [Related]

  • 40. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis.
    Han SH, Bae JH, Holmes DR, Lennon RJ, Eeckhout E, Barsness GW, Rihal CS, Lerman A.
    Eur Heart J; 2008 Jun 07; 29(11):1359-69. PubMed ID: 18424787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.